Outcomes of TAVI devices

Session comprising selected 2021 PCR London Valves Abstract submissions

Presenters: P. Buszman, A. Chatfield, M. Erlebach, S. Ijsselmuiden, G. Jimenez-Rodriguez, N. Van Mieghem, H. Ruge

Summary

This PCR London Valves 2021 session on TAVI compiles the results of various clinical studies conducted on different valve models on the market today and in the future: J-valve, Acurate Neo-2, Perimount P 2900, and many others.

Presentations available when logged in:

Long-term evaluation of novel, transcatheter polymeric aortic valve in ovine aortic banding model
Final five-year outcomes in TAVI patients treated with a repositionable and fully retrievable valve
Bioprosthetic valve fracturing in-vitro study with the Perimount valve model P 2900
The J-valve transcatheter heart valve for high-risk patients with severe pure aortic regurgitation
One-year single-centre experience with the Acurate Neo-2 TAVR device
TAVI with a newer-generation balloon-expandable valve
Propensity matched comparison of transcatheter valves for the treatment of degenerated bioprostheses

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Outcomes of TAVI devices

Session comprising selected 2021 PCR London Valves Abstract submissions

Log in or create account for free